Agios to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021

Rhea-AI Summary

Agios Pharmaceuticals (NASDAQ:AGIO) announced its presentation schedule for the virtual 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 10:50 a.m. ET. Investors can access a live webcast of the event via the company's website, with a replay available for two weeks post-event. Agios is recognized for its focus on developing novel investigational medicines targeting cancer and genetically defined diseases, boasting a robust research pipeline alongside two approved oncology precision medicines.

CAMBRIDGE, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and genetically defined diseases, today announced that the company is scheduled to present at the virtual 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 10:50 a.m. ET.

A live webcast of the presentation and breakout session can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios.com. A replay of the webcast will be archived on the Agios website for at least two weeks following the presentation.

About Agios
Agios is focused on discovering and developing novel investigational medicines to treat malignant hematology, solid tumors and genetically defined diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across these three therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development. For more information, please visit the company's website at www.agios.com.

Contacts

Investors:
Holly Manning, 617-844-6630
Director, Investor Relations
Holly.Manning@agios.com

Media:
Jessica Rennekamp, 857-209-3286
Associate Director, Corporate Communications
Jessica.Rennekamp@agios.com

FAQ

When is Agios Pharmaceuticals presenting at the J.P. Morgan Healthcare Conference?

Agios Pharmaceuticals is scheduled to present on January 11, 2021, at 10:50 a.m. ET.

Where can I watch the Agios presentation at the 39th Annual J.P. Morgan Healthcare Conference?

The presentation can be accessed via a live webcast on Agios's website under the 'Events & Presentations' section.

What is the focus of Agios Pharmaceuticals?

Agios Pharmaceuticals focuses on developing investigational medicines for cancer, malignant hematology, and genetically defined diseases.

How can I access the replay of Agios's J.P. Morgan presentation?

The replay of Agios's presentation will be archived on their website for at least two weeks following the event.